Dopamine transporter SPECT of a liver cirrhotic with atypical parkinsonism.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Industrial Health

• Publication date

  2007-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2486/INDHEALTH.45.497PMID 17634700
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroimaging in manganism.

  2006cited by this paper
• Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity.

  2005cited by this paper
• [18F]FDOPA PET and clinical features in parkinsonism due to manganism

  2005cited by this paper
• Dopamine transporter binding in chronic manganese intoxication

  2003cited by this paper
• Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration.

  2003cited by this paper
• Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease

  2001cited by this paper
• Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis.

  2000cited by this paper
• Acquired hepatocerebral degeneration: MR and pathologic findings.

  1998cited by this paper
• The Basal Ganglia and Portal-Systemic Encephalopathy

  1998cited by this paper
• MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.

  1997cited by this paper
• Increased blood manganese in cirrhotic patients: Relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms

  1996cited by this paper
• Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis.

  1996cited by this paper
• Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy

  1995cited by this paper
• Brain magnetic resonance imaging in non-alcoholic cirrhosis.

  1995cited by this paper
• Increased manganese concentrations in pallidum of cirrhotic patients.

  1995cited by this paper
• Manganese and chronic hepatic encephalopathy.

  1995cited by this paper
• Accumulation of manganese and copper in pallidum of cirrhotic patients: role in the pathogenesis of hepatic encephalopathy?

  1995cited by this paper
• Chronic acquired hepatocerebral degeneration: Case reports and new insights

  1995cited by this paper
• Dystonia, hyperintense basal ganglia, and high whole blood manganese levels in Alagille's syndrome.

  1994cited by this paper
• Manganism and idiopathic parkinsonism

  1994cited by this paper
• Manganese intoxication and chronic liver failure

  1994cited by this paper
• Progression after chronic manganese exposure

  1993cited by this paper
• MR imaging of acquired hepatocerebral degeneration.

  1991cited by this paper
• Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: an MR imaging study.

  1991cited by this paper
• Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis. A controlled study.

  1989cited by this paper
• Acquired hepatocerebral degeneration: MR similarity with Wilson disease.

  1988cited by this paper
• Parkinson's Disease and Movement Disorders

  1988cited by this paper
• Cerebral morphological abnormalities associated with non-alcoholic cirrhosis.

  1986cited by this paper

• The role of presynaptic dopaminergic imaging in acquired neurological conditions affecting basal ganglia: a systematic review

  2025cites this paper
• A Prospective Study of the Prevalence of Parkinsonism in Patients With Liver Cirrhosis

  2020cites this paper
• [11C]dihydrotetrabenazine Positron Emission Tomography in Manganese-Exposed Workers.

  2020cites this paper
• Protein kinase Cδ knockout mice are protected from cocaine-induced hepatotoxicity.

  2019cites this paper
• Recent Updates on Acquired Hepatocerebral Degeneration

  2017cites this paper
• 18F-FP-CIT dopamine transporter PET findings in cirrhotic patients with parkinsonism.

  2017influential citation
• Neuromythology of Manganism

  2015cites this paper
• Manganism in the 21st century: the Hanninen lecture.

  2014influential citation
• Toksiline parkinsonism psühhostimulanti süstivatel noortel narkomaanidel

  2013cites this paper
• Manganese-ephedrone intoxication – pathogenesis of neurological damage and clinical symptomatology

  2013cites this paper
• Toxic Encephalopathy

  2012cites this paper
• Role of glial cells in manganese neurotoxicity

  2012cites this paper
• Pallidal Signal Intensities on T1-weighted MRI are Highly Observed in Advanced Liver Cirrhosis

  2012cites this paper
• Relationship between blood manganese and blood pressure in the Korean general population according to KNHANES 2008.

  2011cites this paper
• Iron deficiency increases blood manganese level in the Korean general population according to KNHANES 2008.

  2011cites this paper
• Manganese and Parkinson's disease: a critical review and new findings.

  2011cites this paper
• Increased risk of parkinsonism among patients with cirrhosis: a 7‐year follow‐up study

  2011cites this paper
• Molecular Imaging: The New Frontier in Neurotoxicology

  2010cites this paper
• Dopaminergic neuronal integrity in parkinsonism associated with liver cirrhosis.

  2010cites this paper
• Manganese and Parkinson’s Disease: A Critical Review and New Findings

  2010cites this paper
• Acquired hepatocerebral degeneration

  2009cites this paper
• Health Effects of Manganese and Some Recent Issues in Manganese Neurotoxicity Research.

  2009cites this paper
• Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre‐synaptic mechanism(s): implications to manganese‐induced parkinsonism

  2008cites this paper